Charles Schwab Investment Management Inc Altimmune, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 211,879 shares of ALT stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

211,879

Previous 211,626 0.12%

Holding current value

$1.46 Million

Previous $1.3 Million 17.55%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$6.02 - $9.85 $1,523 - $2,492	253 Added 0.12%	211,879 $1.53 Million
Q3 2024 Nov 12, 2024	BUY	$5.5 - $8.1 $26,246 - $38,653	4,772 Added 2.31%	211,626 $1.3 Million
Q2 2024 Aug 12, 2024	BUY	$5.91 - $10.23 $379,120 - $656,244	64,149 Added 44.95%	206,854 $1.38 Million
Q4 2023 Feb 06, 2024	BUY	$2.14 - $11.62 $19,923 - $108,182	9,310 Added 6.98%	142,705 $1.61 Million
Q2 2023 Aug 09, 2023	BUY	$3.45 - $5.97 $389,846 - $674,604	112,999 Added 554.03%	133,395 $470,000
Q1 2023 May 11, 2023	BUY	$4.19 - $16.83 $13,081 - $52,543	3,122 Added 18.07%	20,396 $86,000
Q2 2022 Aug 15, 2022	SELL	$3.94 - $11.77 $342,575 - $1.02 Million	-86,948 Reduced 83.43%	17,274 $203,000
Q1 2022 May 13, 2022	BUY	$5.9 - $9.45 $20,071 - $32,148	3,402 Added 3.37%	104,222 $635,000
Q4 2021 Feb 11, 2022	BUY	$8.69 - $12.48 $22,289 - $32,011	2,565 Added 2.61%	100,820 $924,000
Q3 2021 Nov 16, 2021	SELL	$8.43 - $16.81 $963,506 - $1.92 Million	-114,295 Reduced 53.77%	98,255 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $749,151 - $1.25 Million	76,056 Added 55.72%	212,550 $2.09 Million
Q1 2021 May 17, 2021	BUY	$12.71 - $24.31 $190,306 - $363,993	14,973 Added 12.32%	136,494 $1.93 Million
Q4 2020 Feb 16, 2021	BUY	$7.84 - $14.22 $21,356 - $38,735	2,724 Added 2.29%	121,521 $1.37 Million
Q3 2020 Nov 13, 2020	BUY	$9.93 - $33.26 $1.18 Million - $3.95 Million	118,797 New	118,797 $1.57 Million

Others Institutions Holding ALT

# of Institutions

192

Shares Held

39.1M

Call Options Held

926K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $338M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Altimmune, Inc. Transaction History